Real World Utilisation of Raltegravir Once Daily 1200mg (RETRO Study)

Study type

• Study type:
  Non-interventional study
• Scope of the study:
  Drug utilisation

Study drug and medical condition

• Medicinal product name:
  ISENTRESS
• Medical condition to be studied:
  HIV test positive

Population studied

• Age groups:
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)
• Estimated number of subjects:
  300

Study design details

• Main study objective:
  Describe and understand the real world utilisation of raltegravir 1200mg once daily
• Outcomes:
  Patient demographics, baseline clinical and treatment characteristics (co-morbidities, co-medications, AIDS defining illnesses within the last 6 months/ever).ART treatment prior to and initiated with RAL OD. Clinical and treatment characteristics of subjects who remain on RAL OD at the 6 month time point. Laboratory parameters at baseline and 6 months (HIV viral load, CD4 cell count), RAL OD discontinuations at 6 months
• Data analysis plan:
  Descriptive analysis using summary statistics